Health and Biosecurity Governance
The Global Risks Forum (GRF)
Research on pathogens advances vaccines and diagnostics and can also create risks through accidents, theft or misuse. Biological risk governance covers laboratory biosafety, biosecurity, oversight of dual-use research, control of synthetic DNA and the Biological Weapons Convention. This page sets out how biological risk governance works and where it has gaps, the records that show it, and who decides.
GRF · In development · service level R0
Biological risk governance is the set of laws, oversight bodies and agreements that manage risks from research on pathogens and from biological tools. It covers laboratory biosafety and biosecurity, dual-use research review, synthetic DNA screening and the Biological Weapons Convention. Legislatures, funders, institutions and states parties hold the decisions.
For biological risk governance, in GRF's situational-awareness reading, the map opens on population density, night lights and flood water with place names and borders from NASA GIBS, framed on Southern Africa; 3 further NASA layers wait in the list.
The interactive map needs JavaScript; the layer list and sources are below.
Layers 3
People and hazards, for this page
Keyboard, with the map focused
Hold Ctrl or ⌘ and scroll to zoom
Latest available
NASA GIBS / EOSDIS · ASTER GDEM (METI, NASA) · Blue Marble (NASA) · © OpenStreetMap contributors (ODbL) · Natural Earth
Loading the latest NASA imagery.
Drag to move. Ctrl or ⌘ and scroll, pinch or the buttons to zoom; hover for the values under the pointer; reset returns to the region.
For biological risk governance, in GRF's situational-awareness reading, the map opens on population density, night lights and flood water with place names and borders from NASA GIBS, framed on Southern Africa; 3 further NASA layers wait in the list.Satellite and model products as NASA publishes them, each with its own date; indicators, not assessments of any place; claim ceiling INTEGRATED.
Layers and dates
The working screen behind this subject: its structure, terms and states. Names are placeholders and values illustrative.
Biological risk governance · National IHR focal point · Event EV-1737
self-assessment score vs target
Safety, reporting and oversight. The dossier below sets out how the risk develops, what is measured, where the data come from, how it is modelled and who decides.
Biosafety levels set facility and procedural requirements, but most incidents trace to human error, maintenance lapses and training gaps. Practice and culture matter as much as design.
Rules on dual-use research often cover a list of agents or funding sources. Work outside those lists, or privately funded, can fall outside review.
Cheaper gene synthesis, benchtop equipment and AI design tools lower barriers. Screening of DNA orders and customer verification are largely voluntary in many countries.
The Biological Weapons Convention has no verification mechanism. Confidence-building measures are voluntary, and many states do not submit them.
Each term as this page uses it. Where a standard-setting body defines the term, the wording follows that body.
| Term | Definition |
|---|---|
| Biosafety | Containment principles, technologies and practices that prevent accidental exposure to biological agents or their release. |
| Dual-use research of concern | Life sciences research that could be directly misapplied to pose a significant threat to health, agriculture, the environment or security. |
| Confidence-building measures | Voluntary annual declarations by BWC states parties on facilities, research and outbreaks, intended to increase transparency. |
Each indicator carries its unit, its cadence, the kind of source behind it and the evidence label a value would carry. No values are shown: a programme supplies them under its own authority.
| Indicator | Unit | Cadence | Source type | Label |
|---|---|---|---|---|
| Maximum containment laboratories | count by country | periodic | Published mapping studies | ESTIMATED |
| National biosafety and biosecurity legislation | yes or no, by element | on change | Legislation databases | OFFICIAL |
| Confidence-building measure submissions under the BWC | count of states | annual | BWC Implementation Support Unit | OFFICIAL |
| Laboratory incidents reported | count by type | annual | National regulator records | REPORTED |
| Gene synthesis providers screening orders | count of providers | periodic | Industry consortium records | DECLARED |
| Dual-use research reviews conducted | count | annual | Institutional and national records | REPORTED |
The topic as a computational graph: named sources feed the methods, an evidence review gates the outputs, and the decisions stay with the authorities that hold them.
Fig. 02Nodes carry their type, two metric rows and a state; connectors show what feeds what; dashed frames name the owners; the timeline is the cadence. Design of the pipeline, not a record of a run.
Named public datasets and institutional records, each with its licence class. Sources by agreement are used only under their terms and never republished.
| Source | What it gives | Licence class |
|---|---|---|
| BWC confidence-building measures (public submissions) | State declarations on facilities, research and outbreaks | Public portions, UNODA terms |
| Global BioLabs report | Mapping of maximum containment laboratories and governance | Free to read, terms to check |
| WHO Laboratory Biosafety Manual | Risk-based biosafety guidance | Free, WHO terms |
| International Gene Synthesis Consortium harmonized screening protocol | Industry screening practice for synthetic DNA orders | Free to read, terms to check |
| National select agent program reports | Registered entities, inspections and incidents | Public records, terms per agency |
Health and Biosecurity Governance prepares evidence. The decisions below are taken by the authorities named, under their own rules, and never by the platform.
| Who decides | The question | Evidence this page serves |
|---|---|---|
| Legislatures and health or science ministries | What biosafety, biosecurity and dual-use research rules apply | Comparative laws and incident evidence |
| Research funders and institutions | Which research to approve and under what conditions | Review practice and risk assessment methods |
| Gene synthesis providers | How to screen orders and verify customers | Screening protocols and comparable practice |
| States Parties to the BWC | Whether to strengthen compliance and transparency measures | Confidence-building records and review conference outcomes |
The questions concern oversight that keeps pace with science.
Biosafety concerns preventing accidental exposure and release; biosecurity concerns preventing theft, misuse or deliberate harm. Both depend on facilities, training, culture and oversight. Laboratory capacity has expanded globally, and advances in the life sciences have lowered some technical barriers, which places more weight on governance.
Oversight is often fragmented between funders, institutions, national regulators and security agencies. Incident reporting is frequently voluntary or confidential, which limits learning. Internationally, the prohibition of biological weapons is long established, but verification is limited, and norms for dual-use research continue to develop.
| Method or data | What it shows | Limits |
|---|---|---|
| Comparative analysis of oversight systems | How countries govern high-consequence research | Many systems are not publicly documented |
| Incident and near-miss analysis | Failure patterns in laboratories | Under-reporting limits evidence |
| Policy analysis of international regimes | Obligations and gaps | Verification and compliance data are limited |
| Expert elicitation | Views on emerging risks | Judgement, not measurement |
The current service level is R0: information and enquiries. An enquiry receives a reference and names the next step; applications, payments, compute allocations and registrations open only when their team, terms and review capacity exist.